financetom
Business
financetom
/
Business
/
Apparel retailer Express files for US bankruptcy protection, to close over 100 stores
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apparel retailer Express files for US bankruptcy protection, to close over 100 stores
Apr 22, 2024 12:46 AM

(Reuters) - Fashion retailer Express Inc ( EXPR ) has filed for Chapter 11 bankruptcy in the United States and intends to close more than 100 stores, it said on Monday.

The retailer whose portfolio includes brands such as Express, Bonobos and UpWest Express, listed assets and liabilities in the range of $1 billion to $10 billion, according to a filing with the bankruptcy court in Delaware.

The company also named Mark Still as its new CFO, effective immediately. The executive has served as interim CFO since November 2023.

As part of the bankruptcy process, the company will close approximately 95 Express retail stores and all of its UpWest stores, starting Tuesday, it said, without specifying the locations.

The company operates about 530 Express retail and Express Factory Outlet stores in the United States and Puerto Rico and around 12 UpWest retail stores, according to its website.

Launched in 1980, Express has been battling with soft consumer demand due to slowing spending patterns and increased price sensitivity in discretionary categories.

Express has received a commitment for $35 million in new financing from some of its existing lenders, it said.

The multi-brand fashion retailer said it expects to conduct business as usual as it initiates a court-supervised process to facilitate a formal sale process.

The company said on Monday that it received a non-binding letter of intent from a consortium led by WHP Global for the sale of a substantial majority of its retail stores and operations.

Brand management firm WHP Global, which owns Toys "R" Us and fashion labels such as Anne Klein, took a 7.4% stake in Express last year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China's February auto sales, exports fall at fastest pace in two years
China's February auto sales, exports fall at fastest pace in two years
Mar 10, 2026
BEIJING, March 11 (Reuters) - China's auto sales, including shipments abroad, fell 15.4% in February from a year earlier, the biggest decline since February 2024, as seasonal factors aggravated a downtrend in the world's largest auto market, where reduced incentives weigh on demand. Sales at home plunged 34.2% to 0.95 million vehicles, dampening a rise of 58% in exports which...
France's Thales launches European anti-missile defence dome
France's Thales launches European anti-missile defence dome
Mar 10, 2026
PARIS, March 11 (Reuters) - France's Thales said on Wednesday it had launched a new integrated air and missile defence system, tying together existing capabilities and incorporating artifical intelligence. The SkyDefender system is a multi-layer defence dome capable of countering all kinds of threats on land and sea and in space, Europe's largest defence technology firm said in a statement....
Mobileye Global to Acquire Mentee Robotics
Mobileye Global to Acquire Mentee Robotics
Mar 10, 2026
04:46 PM EST, 01/06/2026 (MT Newswires) -- Mobileye Global ( MBLY ) said late Tuesday it has struck a deal to acquire Mentee Robotics for about $900 million to scale autonomous vehicles and humanoid robots. The transaction, which is subject to adjustment, is comprised of about $612 million in cash and up to about 26.2 million in shares, the company...
Market Chatter: Eli Lilly in Advanced Talks to Buy Ventyx Biosciences for Over $1 Billion
Market Chatter: Eli Lilly in Advanced Talks to Buy Ventyx Biosciences for Over $1 Billion
Mar 10, 2026
04:49 PM EST, 01/06/2026 (MT Newswires) -- Eli Lilly ( LLY ) is in advanced conversations to acquire Ventyx Biosciences ( VTYX ) for more than $1 billion, The Wall Street Journal reported Tuesday, quoting unnamed sources familiar with the matter. Ventyx develops pills to treat diseases like Crohn's and rheumatoid arthritis, the report said, adding one of Ventyx's drug...
Copyright 2023-2026 - www.financetom.com All Rights Reserved